Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B

  1. Buti, M.
  2. Casado, M.A.
  3. Calleja, J.L.
  4. Salmerón, J.
  5. Aguilar, J.
  6. Rueda, M.
  7. Esteban, R.
Aldizkaria:
Alimentary Pharmacology and Therapeutics

ISSN: 0269-2813,  1365-2036

Argitalpen urtea: 2006

Alea: 23

Zenbakia: 3

Orrialdeak: 409-419

Mota: Artikulua

DOI: 10.1111/J.1365-2036.2006.02767.X GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus